Dr. Reddy’s Laboratories announces the launch of Versavo® (bevacizumab biosimilar) in India
Hyderabad, India, August 19, 2019 (GPN) — Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Versavo® (bevacizumab), a biosimilar of Roche’s Avastin® in India, indicated for the treatment of several…